GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

National Healthcare Properties, NHP · USD

US listing · 🇺🇸 United States

Compare

15.95

+4.66%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$342.3m

FY2022FY2025

Net income

−$57.6m

FY2022FY2025

Free cash flow

−$21.8m

FY2022FY2025

Shareholders' equity

$600.1m

FY2022FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022
Revenue$342.3m$353.8m$345.9m$335.8m
Gross profit$123.4m$132.3m$128.1m$122.4m
Operating income$3.3m−$120.6m−$6.7m−$27.7m
Net income−$57.6m−$189.7m−$72.3m−$79.5m
Diluted earnings per share-2.03-6.71-2.56-2.81

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022
Total assets$1.71bn$1.95bn$2.15bn$2.18bn
Cash and short-term investments$57.6m$21.7m$46.4m—
Total liabilities$1.11bn$1.26bn$1.24bn$1.18bn
Debt$1.04bn$1.14bn$1.17bn$578.7m
Shareholders' equity$600.1m$684.6m$894.2m$992.6m
Shares outstanding28m28m28m28m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022
Cash from operations$7.0m−$79.8m$21.6m$28.3m
Capital spending−$28.7m−$21.9m−$22.4m−$28.0m
Free cash flow−$21.8m−$101.8m−$773,000$302,000
Dividends paid−$13.4m−$13.8m−$13.8m−$13.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024
Revenue$87.5m$86.3m$84.5m$86.0m$85.3m$86.4m$87.7m
Gross profit−$2.2m$33.4m$31.5m$32.2m$31.5m$28.9m$33.1m
Operating income$8.9m$10.2m−$6.6m$2.4m−$5.5m$13.0m−$1.1m
Net income−$5.4m−$4.3m−$22.7m−$12.6m−$20.8m−$1.6m−$17.0m
Diluted earnings per share-0.09-0.07-0.80-0.44-0.73-0.06-0.60
Cash from operations—$9.0m$9.0m$10.0m$8.0m−$21.0m$6.0m
Capital spending—−$5.0m−$11.0m−$4.0m−$6.0m−$5.0m−$5.0m
Free cash flow—$4.0m−$2.0m$6.0m$2.0m−$26.0m$1.0m
Total assets$1.98bn$1.70bn$1.71bn$1.74bn$1.76bn$1.83bn$1.95bn
Cash and short-term investments$302.4m$106.6m$57.6m$47.1m$47.1m$71.4m$21.7m
Debt—$1.18bn$1.04bn$1.03bn$1.03bn$1.07bn$362.2m
Shareholders' equity$1.05bn$592.2m$600.1m$627.2m$647.0m$674.6m$684.6m

Financial ratios

Data as of 5 Nov 2026

FY2025FY2024FY2023FY2022
Gross margin36.0%37.4%37.0%36.4%
Operating margin1.1%-34.1%-1.7%-8.2%
Net margin-16.8%-53.6%-20.9%-23.7%
Return on equity-9.6%-27.7%-8.1%-8.0%
Return on assets-3.4%-9.7%-3.4%-3.6%
Free cash flow yield8.0%-13.0%——
Revenue growth-3.3%2.3%3.0%—
Earnings growth-69.6%162.4%-9.0%—
Current ratio0.24x0.22x0.28x0.17x
Debt to equity1.73x1.67x1.31x0.58x
Equity ratio35.1%35.2%41.7%45.5%
Interest coverage0.06x-1.74x-0.09x-0.53x
Buybacks as a share of market value-0.1%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-0.4%——
Net income-10.2%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin36.7%36.7%——

Market value over time

30 Apr 2026 to 4 Nov 2026, in USD

$363.3m$973.2m

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 9 Oct 2026.

FY2026
Paid in the year0.15

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.